NAMPT and neoplasm: Nicotinamide phosphoribosyltransferase (NAMPT) drives tumor immune evasion by inducing PD-L1 expression in multiple types of tumors, but enhances the efficacy of immune checkpoint inhibitors (Lv et al., 2020).